Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04128267 · ClinicalTrials.gov registry record · NA
Central Pain Syndrome in Survivors of Head and Neck Cancer
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT04128267 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 32 participants.
The verdict
NCT04128267, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
Interventions
- DEVICE Magnetic resonance imaging
- OTHER Correlative Studies
- DEVICE IPC-1000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2022-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04128267
The ClinicalTrials.gov registry entry for NCT04128267 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Magnetic resonance imaging is the first listed.
NCT04128267 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04128267 about?
NCT04128267 is a clinical study titled "Central Pain Syndrome in Survivors of Head and Neck Cancer". This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
What is the current status of trial NCT04128267?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2019-11-04. Estimated completion is 2022-07-21.
What interventions are being tested in trial NCT04128267?
The interventions under investigation include: Magnetic resonance imaging (DEVICE), Correlative Studies (OTHER), IPC-1000 (DEVICE).
Who is sponsoring clinical trial NCT04128267?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.